Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$435,559
-$72,352 QoQ
Shares Held
18,088
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,854
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bond & Devick Financial Network, Inc. holds $6,097,156 across 9 Drug Manufacturers - General names. PFE ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,177 | $1,822,742 | |
| 2 | AMGN |
Amgen Inc
|
3,711 | $1,343,827 | |
| 3 | NVO |
Novo Nordisk A S
|
15,422 | $739,330 | |
| 4 | GSK |
GSK plc
|
8,530 | $447,142 | |
| 5 | LLY |
ELI LILLY & Co
|
364 | $436,592 | |
| 6 | PFE |
Pfizer Inc
This page
|
18,088 | $435,559 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,927 | $376,119 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,156 | $272,389 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $435,559 | 18,088 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $507,911 | 18,088 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $455,371 | 18,288 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $465,978 | 18,288 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $427,690 | 17,644 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $529,707 | 20,904 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $492,900 | 18,579 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $537,676 | 18,579 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $491,860 | 17,579 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $346,292 | 12,479 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $293,053 | 10,179 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $287,882 | 8,679 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $333,017 | 9,079 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $317,383 | 7,779 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $398,595 | 7,779 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $340,409 | 7,779 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $386,880 | 7,379 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $382,010 | 7,379 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $447,539 | 7,579 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $325,972 | 7,579 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $294,718 | 7,526 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $272,666 | 7,526 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $277,032 | 7,526 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||